We're investing in pioneering, UK-focused, early stage healthcare businesses in the HealthTech sector.
One healthy investment at a time.
What we look for
We want to hear from like-minded ground-breaking companies that focus on UK healthcare, who are ideally at Seed to Series B stage.
Our next investment partner has:
Big ideas and clear plans to execute with demonstrable product market fit and ambitious plans to scale
Operations in the UK
Where appropriate, the ability to improve the Simplyhealth Group's core value proposition
A track record to be proud of, industry credibility and technical kudos
Bags of energy and business drive
What we offer
A unique and attractive proposition for HealthTech start-ups as a purpose-led Group, only investing our own capital to help transform the UK healthcare economy.
Brand reputation - Simplyhealth has a strong reputation in UK healthcare
Internal expertise - Over 150 years of knowledge and healthcare experience combined with an incubator mentality
A significant customer base - which could be leveraged to accelerate growth plans where the technology aligns to our product roadmap – a classic corporate venture approach
Financial investment - we have a multi-year deployment plan investing £500k to £2m initially
We strongly believe in backing fantastic management teams with great ideas. People are at the heart of everything we do.
We've identified core areas for the fund to concentrate on:
Areas in which the NHS cannot continue to serve effectively
Mental health support
Weight loss support, linked to medical condition management
Dental
Scans
Testing
Post-acute care support
Gut health
Female health
Chronic condition management
Secondary care technologies
Genomics
We're embracing the rapid change in UK healthcare and are committed to supporting companies with the same vision to provide better access to healthcare for all in the UK.
Our portfolio
Find out more about the exciting start-ups and businesses that we're supporting, that will shape the future of healthcare in the UK.
Meet the team
Learn more about our expert investors and get in touch with the team.